Literature DB >> 14745691

Prospects for preventing serious systemic toxemic complications of Shiga toxin-producing Escherichia coli infections using Shiga toxin receptor analogues.

Mohamed A Karmali.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745691     DOI: 10.1086/381130

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  16 in total

1.  Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors.

Authors:  Christian H Schweppe; Petra Hoffmann; Jerzy-Roch Nofer; Gottfried Pohlentz; Michael Mormann; Helge Karch; Alexander W Friedrich; Johannes Müthing
Journal:  J Lipid Res       Date:  2010-05-05       Impact factor: 5.922

2.  DAP1, a negative regulator of autophagy, controls SubAB-mediated apoptosis and autophagy.

Authors:  Kinnosuke Yahiro; Hiroyasu Tsutsuki; Kohei Ogura; Sayaka Nagasawa; Joel Moss; Masatoshi Noda
Journal:  Infect Immun       Date:  2014-09-02       Impact factor: 3.441

3.  Enteric Pathogens Exploit the Microbiota-generated Nutritional Environment of the Gut.

Authors:  Alline R Pacheco; Vanessa Sperandio
Journal:  Microbiol Spectr       Date:  2015-06

Review 4.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

5.  Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity.

Authors:  Christian H Schweppe; Martina Bielaszewska; Gottfried Pohlentz; Alexander W Friedrich; Heino Büntemeyer; M Alexander Schmidt; Kwang S Kim; Jasna Peter-Katalinić; Helge Karch; Johannes Müthing
Journal:  Glycoconj J       Date:  2008-01-05       Impact factor: 2.916

6.  Hemolytic uremic syndrome: new developments in pathogenesis and treatment.

Authors:  Olivia Boyer; Patrick Niaudet
Journal:  Int J Nephrol       Date:  2011-08-17

Review 7.  Shiga toxin-producing Escherichia coli: factors involved in virulence and cattle colonization.

Authors:  Analía Inés Etcheverría; Nora Lía Padola
Journal:  Virulence       Date:  2013-04-15       Impact factor: 5.882

Review 8.  Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies.

Authors:  Alline R Pacheco; Vanessa Sperandio
Journal:  Front Cell Infect Microbiol       Date:  2012-06-07       Impact factor: 5.293

9.  Antibody responses elicited in mice immunized with Bacillus subtilis vaccine strains expressing Stx2B subunit of enterohaemorragic Escherichia coli O157:H7.

Authors:  P A D P Gomes; L V Bentancor; J D Paccez; M E Sbrogio-Almeida; M S Palermo; R C C Ferreira; L C S Ferreira
Journal:  Braz J Microbiol       Date:  2009-06-01       Impact factor: 2.476

Review 10.  Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.

Authors:  Lindsay S Keir; Stephen D Marks; Jon Jin Kim
Journal:  Drug Des Devel Ther       Date:  2012-07-19       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.